Fan X, Wei C, Rong M, Wang S, et al. Clinical implications of PD-L1 expression in oncogene-driven NSCLC: Differential responses to targeted agents and immune checkpoint inhibitors. Int J Cancer 2026;159:269-279.
PMID: 41872688